-
Lnc21q22.11 Suppresses Gastric Cancer via MEK/ERK
2026-09-18
The 2025 reference study identifies Lnc21q22.11 as a previously uncharacterized 1,202-nucleotide lncRNA that is reduced in gastric cancer and suppresses tumor-associated phenotypes. Its interaction with MYH9 links lncRNA biology to MEK/ERK signaling, while the associated inhibitor-sensitivity result suggests a testable preclinical vulnerability rather than an established clinical treatment strategy.
-
KU-55933: ATM Kinase Inhibitor Workflows
2026-09-18
KU-55933 enables controlled interrogation of ATM-dependent DNA damage signaling, Akt phosphorylation, cell-cycle behavior, and metabolic stress. This practical guide connects ATM inhibition with the nuclear cGAS–TRIM41–ORF2p axis while distinguishing established product performance from hypothesis-generating assay extensions.
-
Dual-Network EGCG Microgels for Disc Degeneration
2026-09-17
The reference study develops an elastic, stimulus-responsive microsphere that combines miR-155 delivery with the antioxidant and inflammation-modulating functions of EGCG. In cellular and animal models of intervertebral disc degeneration, the platform reduced inflammatory injury, limited nucleus pulposus cell apoptosis, and supported restoration of disc-cell function.
-
PM2.5, Fra2/LCN2, and M2 Macrophage Ferroptosis
2026-09-17
This 2026 Redox Biology study identifies a Fra2/LCN2-driven mechanism linking PM2.5 exposure to mitophagy dysfunction, M2 macrophage ferroptosis, and worsened asthma. Its combination of multi-omics, promoter-binding analysis, cellular assays, and macrophage-specific LCN2 knockdown provides a useful framework for studying environmental aggravation of airway disease.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-09-16
This 2025 review integrates tumor hypoxia, metabolic competition, and immune-cell dysfunction into a dynamic model of immunosuppressive tumor-microenvironment evolution. Its main practical implication is that glucose and other nutrient pathways should be interpreted together with oxygen availability, immune phenotype, and spatial context rather than as isolated metabolic variables.
-
2,7-Dichlorodihydrofluorescein diacetate: ROS Workflow
2026-09-16
Build a defensible intracellular ROS workflow with DCFH-DA for microscopy, flow cytometry, and plate assays. This guide translates melatonin–autophagy findings in hypertrophic-scar fibroblasts into practical redox assay design while highlighting probe limitations and troubleshooting controls.
-
MDV3100: AR Signaling Workflow Guide
2026-09-15
Build cleaner androgen receptor studies with MDV3100 (Enzalutamide), from compound preparation and nuclear-translocation assays to apoptosis and resistance profiling. The workflow also translates recent AR/ARv7 findings in triple-negative breast cancer into practical assay-selection and troubleshooting decisions.
-
BCECF-AM and Plant Autophagy: Reading Vacuolar pH
2026-09-15
BCECF-AM enables ratiometric intracellular pH measurement that can reveal whether impaired plant autophagy reflects defective vacuolar acidification. This article connects BCECF-AM assay design with SINAT–VAB1 regulation in Arabidopsis and explains the practical limits of interpreting whole-cell pH signals.
-
Recombinant Human FGF-19 Renal Workflows
2026-09-14
Recombinant Human FGF-19 supports controlled FGFR4 signaling, metabolic regulation research, and exploratory renal injury studies in one tag-free format. This practical guide combines reconstitution, dose finding, receptor-aware controls, and p38 MAPK–pyroptosis readouts without overstating evidence for a pathway that remains to be tested.
-
Tamsulosin: From Stone Evidence to Assay Design
2026-09-14
Tamsulosin links α₁A-receptor pharmacology with clinically measured ureteral stone passage. This article translates meta-analytic evidence into a tiered assay strategy, formulation plan, and interpretation framework for translational researchers.
-
Budesonide in Lung Permeability Research
2026-09-13
Budesonide can serve as a translational probe linking glucocorticoid-driven control of airway inflammation with biomimetic permeability testing. This workflow helps distinguish lipid partitioning, phospholipid interactions, and biological response when developing asthma inflammation models and broader respiratory disease research assays.
-
PDGF-BB in Pulmonary Hypertension Research
2026-09-12
A translational framework for using murine recombinant PDGF-BB as a defined mitogenic perturbation in pulmonary hypertension research, linking PDGFR signaling and smooth muscle cell proliferation with the lactate–ALDOB–DRP1 mechanism described in recent pulmonary vascular biology.
-
QX77: Molecular Chaperone Activator for CMA
2026-09-11
QX77 is a molecular chaperone activator described for LAMP2A upregulation, Rab11-associated trafficking rescue, and chaperone-mediated autophagy research. Its reported effects on ES cell self-renewal and differentiation support stem cell biology research, but the compound has not been clinically validated or directly tested in the cited bronchopulmonary dysplasia study.
-
17-AAG (Tanespimycin) Workflow Guide
2026-09-11
Build more informative HSP90 experiments by pairing 17-AAG dose-response profiling with client-protein, signaling, apoptosis, and membrane-release readouts. This workflow also shows how the NINJ1 norovirus study can inspire assay controls without overstating evidence for an antiviral role.
-
Danazol C3644 for Reliable Cell Assays
2026-09-10
Learn how Danazol (SKU C3644) can support better-controlled endocrine, viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects mechanism, formulation, storage, vendor selection, and interpretation limits to practical laboratory decisions.